Search results
Results from the WOW.Com Content Network
In July 2021, the U.S. Food and Drug Administration (FDA) approved Tanovea to treat lymphoma in dogs. [6] Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many species, including dogs. [6] Rabacfosadine is the first conditionally approved new animal drug for dogs to achieve the FDA's full approval. [6]
The Consumer Health Product Database is a web-based application that allows the public to search for specific products or specific chemical ingredients. It is a collection of publicly available information, mostly from product labels and Safety Data Sheets (former MSDS) provided by the product's manufacturer. [ 1 ]
The main criterion for the inclusion of any product is that the product is the subject of an application with an effective approval that has not been withdrawn for safety or efficacy reasons. Inclusion of products on the List is independent of any current regulatory action through administrative or judicial means against a drug product.
Before a drug can be prescribed, it must undergo the FDA's approval process. While a drug can feasibly be used off-label (for non-approved indications), it still is required to be approved for a specific disease or medical condition. [2] Drug companies seeking to sell a drug in the United States must first test it.
Drug Manufacturer Indication Crizotinib: PF Prism: ALK-positive systemic anaplastic large cell lymphoma: Trastuzumab deruxtecan: Daiichi Sankyo: HER2-positive gastric or gastroesophageal junction adenocarcinoma, previously treated with trastuzumab: Umbralisib: TG Therapeutics: marginal zone lymphoma, previously treated with an anti-CD20-based ...
Food and Drug Administration Substance Registration System U.S. National Library of Medicine: ingredients in FDA regulated products UNII inchikey "FDA SRS". 781,000 FEMA Flavor Ingredient Library: Flavor and Extract Manufacturers Association: CAS CFR FEMA number "FEMA". FooDB: Food Database University of Alberta Food components and additives ...
Alipogene tiparvovec (Glybera): AAV-based treatment for lipoprotein lipase deficiency (no longer commercially available); Axicabtagene ciloleucel (Yescarta): treatment for large B-cell lymphoma [1]
The GSRS is a freely distributable software system provided through a collaboration between the FDA, the National Center for Advancing Translational Sciences (NCATS) and the European Medicines Agency (EMA). [1] The GSRS was developed to implement the ISO 11238 standard which is one of the core ISO Identification of Medicinal Product (IDMP ...